|
1
|
Cao SM, Simons MJ and Qian CN: The
prevalence and prevention of nasopharyngeal carcinoma in China.
Chin J Cancer. 30:114–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y, Lin ZA, Pan JJ, et al: Concurrent
control study of different radiotherapy for primary nasopharyngeal
carcinoma: intensity-modulated radiotherapy versus conventional
radiotherapy. Ai Zheng. 28:1143–1148. 2009.(In Chinese).
|
|
4
|
Wu Y and Zhou BP: New insights of
epithelial-mesenchymal transition in cancer metastasis. Acta
Biochim Biophys Sin. 40:643–650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: new insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao D, Vahdat LT, Wong S, Chang JC and
Mittal V: Microenvironmental regulation of epithelial-mesenchymal
transitions in cancer. Cancer Res. 72:4883–4889. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Talbot LJ, Bhattacharya SD and Kuo PC:
Epithelial-mesenchymal transition, the tumor microenvironment, and
metastatic behavior of epithelial malignancies. Int J Biochem Mol
Biol. 3:117–136. 2012.PubMed/NCBI
|
|
8
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wells A, Yates C and Shepard CR:
E-cadherin as an indicator of mesenchymal to epithelial reverting
transitions during the metastatic seeding of disseminated
carcinomas. Clin Exp Metastasis. 25:621–628. 2008. View Article : Google Scholar
|
|
11
|
Chao YL, Shepard CR and Wells A: Breast
carcinoma cells re-express E-cadherin during mesenchymal to
epithelial reverting transition. Mol Cancer. 9:1792010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng H and Kang Y: Multilayer control of
the EMT master regulators. Oncogene. 33:1755–1763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee YJ and Han HJ: Troglitazone
ameliorates high glucose-induced EMT and dysfunction of SGLTs
through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal
tubule cells. Am J Physiol Renal Physiol. 298:F1263–F1275.
2010.PubMed/NCBI
|
|
14
|
Nicholson KM and Anderson NG: The protein
kinase B/Akt signalling pathway in human malignancy. Cell Signal.
14:381–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheng S, Qiao M and Pardee AB: Metastasis
and AKT activation. J Cell Physiol. 218:451–454. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grille SJ, Bellacosa A, Upson J, et al:
The protein kinase Akt induces epithelial mesenchymal transition
and promotes enhanced motility and invasiveness of squamous cell
carcinoma lines. Cancer Res. 63:2172–2178. 2003.PubMed/NCBI
|
|
17
|
Shen Z, Zeng Y, Guo J, et al:
Over-expression of the special AT rich sequence binding protein 1
(SATB1) promotes the progression of nasopharyngeal carcinoma:
association with EBV LMP-1 expression. J Transl Med. 11:2172013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen Z, Jiang X, Zeng C, et al: High
expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates
with nasopharyngeal carcinoma progression. BMC Cancer. 13:1922013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jie W, He QY, Luo BT, et al: Inhibition of
Pim-1 attenuates the proliferation and migration in nasopharyngeal
carcinoma cells. Asian Pac J Trop Med. 5:645–650. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang H, Fan D, Zhou G, Li X and Deng H:
Phosphatidylinositol 3-kinase inhibitor (LY294002) induces
apoptosis of human nasopharyngeal carcinoma in vitro and in vivo. J
Exp Clin Cancer Res. 29:342010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hong KO, Kim JH, Hong JS, et al:
Inhibition of Akt activity induces the mesenchymal-to-epithelial
reverting transition with restoring E-cadherin expression in KB and
KOSCC-25B oral squamous cell carcinoma cells. J Exp Clin Cancer
Res. 28:282009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo WR, Chen XY, Li SY, Wu AB and Yao KT:
Neoplastic spindle cells in nasopharyngeal carcinoma show features
of epithelial-mesenchymal transition. Histopathology. 61:113–122.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li XJ, Peng LX, Shao JY, et al: As an
independent unfavorable prognostic factor, IL-8 promotes metastasis
of nasopharyngeal carcinoma through induction of
epithelial-mesenchymal transition and activation of AKT signaling.
Carcinogenesis. 33:1302–1309. 2012. View Article : Google Scholar
|
|
25
|
Horikawa T, Yang J, Kondo S, et al: Twist
and epithelial-mesenchymal transition are induced by the EBV
oncoprotein latent membrane protein 1 and are associated with
metastatic nasopharyngeal carcinoma. Cancer Res. 67:1970–1978.
2007. View Article : Google Scholar
|
|
26
|
Chen XF, Zhang HJ, Wang HB, et al:
Transforming growth factor-β1 induces epithelial-to-mesenchymal
transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2
signaling pathways. Mol Biol Rep. 39:3549–3556. 2012.
|
|
27
|
Kang MH, Kim JS, Seo JE, Oh SC and Yoo YA:
BMP2 accelerates the motility and invasiveness of gastric cancer
cells via activation of the phosphatidylinositol 3-kinase
(PI3K)/Akt pathway. Exp Cell Res. 316:24–37. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ding S, Zhang W, Xu Z, et al: Induction of
an EMT-like transformation and MET in vitro. J Transl Med.
11:1642013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Battula VL, Evans KW, Hollier BG, et al:
Epithelial-mesenchymal transition-derived cells exhibit
multilineage differentiation potential similar to mesenchymal stem
cells. Stem Cells. 28:1435–1445. 2010. View
Article : Google Scholar
|
|
31
|
Kong QL, Hu LJ, Cao JY, et al:
Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal
transition and increases the number of side population stem-like
cancer cells in nasopharyngeal carcinoma. PLoS Pathog.
6:e10009402010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo D, Xu BL, Zhang XH and Dong MM: Cancer
stem-like side population cells in the human nasopharyngeal
carcinoma cell line CNE-2 possess epithelial mesenchymal transition
properties in association with metastasis. Oncol Rep. 28:241–247.
2012.
|
|
33
|
Lin CH, Shen YA, Hung PH, Yu YB and Chen
YJ: Epigallocathechin gallate, polyphenol present in green tea,
inhibits stem-like characteristics and epithelial-mesenchymal
transition in nasopharyngeal cancer cell lines. BMC Complement
Altern Med. 12:2012012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jazirehi AR, Wenn PB and Damavand M:
Therapeutic implications of targeting the PI3Kinase/AKT/mTOR
signaling module in melanoma therapy. Am J Cancer Res. 2:178–191.
2012.PubMed/NCBI
|
